JP2024539655A5 - - Google Patents
Info
- Publication number
- JP2024539655A5 JP2024539655A5 JP2024522548A JP2024522548A JP2024539655A5 JP 2024539655 A5 JP2024539655 A5 JP 2024539655A5 JP 2024522548 A JP2024522548 A JP 2024522548A JP 2024522548 A JP2024522548 A JP 2024522548A JP 2024539655 A5 JP2024539655 A5 JP 2024539655A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- hydrogen
- unsubstituted alkyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255272P | 2021-10-13 | 2021-10-13 | |
| US63/255,272 | 2021-10-13 | ||
| PCT/US2022/046386 WO2023064343A1 (en) | 2021-10-13 | 2022-10-12 | Small molecule modulators of glucocerebrosidase activity and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539655A JP2024539655A (ja) | 2024-10-29 |
| JP2024539655A5 true JP2024539655A5 (enExample) | 2025-10-20 |
Family
ID=85988704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522548A Pending JP2024539655A (ja) | 2021-10-13 | 2022-10-12 | グルコセレブロシダーゼ活性の小分子モジュレーターおよびその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20250034170A1 (enExample) |
| EP (1) | EP4415706A4 (enExample) |
| JP (1) | JP2024539655A (enExample) |
| KR (1) | KR20240102969A (enExample) |
| CN (1) | CN118382436A (enExample) |
| AR (1) | AR127355A1 (enExample) |
| AU (1) | AU2022364718A1 (enExample) |
| CA (1) | CA3235270A1 (enExample) |
| CL (1) | CL2024001109A1 (enExample) |
| IL (1) | IL312086A (enExample) |
| JO (1) | JOP20240081A1 (enExample) |
| MX (1) | MX2024004581A (enExample) |
| PE (1) | PE20242105A1 (enExample) |
| TW (1) | TW202327586A (enExample) |
| WO (1) | WO2023064343A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024355840A1 (en) * | 2023-10-04 | 2026-03-19 | The Board Of Trustees Of The University Of Illinois | Fused heterocycles for treating neurodegenerative diseases |
| WO2025237303A1 (zh) * | 2024-05-14 | 2025-11-20 | 先声药业有限公司 | β-葡萄糖脑苷脂酶变构调节剂、其药物组合物及用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0302811D0 (sv) * | 2003-10-23 | 2003-10-23 | Astrazeneca Ab | Novel compounds |
| DE102005030051A1 (de) * | 2005-06-27 | 2006-12-28 | Grünenthal GmbH | Substituierte 1-Oxa-3,8-diazaspiro[4,5]-decan-2-on-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
| GB0601402D0 (en) * | 2006-01-24 | 2006-03-08 | Syngenta Participations Ag | Chemical Compounds |
| JP2010503676A (ja) * | 2006-09-15 | 2010-02-04 | シェーリング コーポレイション | 疼痛、糖尿病および脂質代謝の障害の治療 |
| AR074558A1 (es) * | 2008-12-12 | 2011-01-26 | Solvay Pharm Bv | Espiro azepan oxazolidinonas como bloqueadores del canal de potasio kv1.3 |
| US8828996B2 (en) * | 2011-03-14 | 2014-09-09 | Vertex Pharmaceuticals Incorporated | Morpholine-spirocyclic piperidine amides as modulators of ion channels |
| EP3087056A4 (en) * | 2013-12-23 | 2017-07-19 | Alectos Therapeutics Inc. | Glucocerebrosidase modulators and uses thereof |
-
2022
- 2022-10-12 AU AU2022364718A patent/AU2022364718A1/en active Pending
- 2022-10-12 CN CN202280081938.3A patent/CN118382436A/zh active Pending
- 2022-10-12 EP EP22881696.3A patent/EP4415706A4/en active Pending
- 2022-10-12 TW TW111138643A patent/TW202327586A/zh unknown
- 2022-10-12 WO PCT/US2022/046386 patent/WO2023064343A1/en not_active Ceased
- 2022-10-12 PE PE2024000819A patent/PE20242105A1/es unknown
- 2022-10-12 JP JP2024522548A patent/JP2024539655A/ja active Pending
- 2022-10-12 US US18/700,625 patent/US20250034170A1/en active Pending
- 2022-10-12 CA CA3235270A patent/CA3235270A1/en active Pending
- 2022-10-12 AR ARP220102783A patent/AR127355A1/es unknown
- 2022-10-12 MX MX2024004581A patent/MX2024004581A/es unknown
- 2022-10-12 IL IL312086A patent/IL312086A/en unknown
- 2022-10-12 KR KR1020247015816A patent/KR20240102969A/ko active Pending
-
2024
- 2024-04-11 CL CL2024001109A patent/CL2024001109A1/es unknown
- 2024-04-14 JO JOJO/P/2024/0081A patent/JOP20240081A1/ar unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008513498A5 (enExample) | ||
| JP6938561B2 (ja) | 重水素化２，４−チアゾリジンジオン及び治療方法 | |
| EP2046775B1 (fr) | Derives de n- (amino-heteroaryl) - 1h-indole-2 -carboxamides comme antagonistes des recepteurs de type trpv1 ou vr1 | |
| JP5715340B2 (ja) | Ｎａｄｐｈオキシダーゼインヒビターとしてのピラゾロピリジン誘導体 | |
| JP2021534124A5 (enExample) | ||
| JP2008513506A5 (enExample) | ||
| JP2008513516A5 (enExample) | ||
| JP2011526926A5 (enExample) | ||
| RU2006105717A (ru) | Производные пиперазина и их применение в качестве терапевтических агентов | |
| WO2000012487A1 (en) | Pyrimidine derivatives | |
| JP2008513496A5 (enExample) | ||
| JP2011520792A5 (enExample) | ||
| CA3157798A1 (en) | 6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity | |
| CN103012378A (zh) | 作为5-ht2a血清素受体调节剂适用于治疗与其相关的病症的3-苯基-吡唑衍生物 | |
| JP2008513504A5 (enExample) | ||
| US20160000783A1 (en) | Trk-INHIBITING COMPOUND | |
| CA2658799A1 (fr) | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
| WO2004083167A1 (ja) | スルファミド誘導体及びその医薬組成物 | |
| WO1998029397A1 (en) | Fused pyrimidine compounds and medicinal use thereof | |
| US20190389865A1 (en) | SUBSTITUTED PYRROLO[1,2-a]TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS | |
| JP2011517443A5 (enExample) | ||
| US10308647B2 (en) | Fused imidazole derivatives as IDO/TDO inhibitors | |
| CA2615611A1 (en) | Indazole derivatives | |
| JP2009502770A5 (enExample) | ||
| US20120058085A1 (en) | Deuterium Modified Benzimidazoles |